News
Swiss pharmaceuticals company Roche announces $50 billion investment in US over next 5 years
The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Massachusetts, California, Indiana, and Pennsylvania.
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...
Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...
Roche introduces its chest pain triage algorithm in collaboration with Universitätsklinikum Heidelberg to enhance detection of ACS: Basel Thursday, April 24, 2025, 09:00 Hrs [IST ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide ...
Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback